Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Escalade (ESCA) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Escalade (ESCA) over the last 15 years, with Q3 2025 value amounting to $5.6 million.

  • Escalade's Net Income towards Common Stockholders fell 199.4% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 798.54%. This contributed to the annual value of $13.0 million for FY2024, which is 5389.9% up from last year.
  • Escalade's Net Income towards Common Stockholders amounted to $5.6 million in Q3 2025, which was down 199.4% from $1.8 million recorded in Q2 2025.
  • Escalade's Net Income towards Common Stockholders' 5-year high stood at $8.1 million during Q3 2021, with a 5-year trough of -$952000.0 in Q1 2023.
  • In the last 5 years, Escalade's Net Income towards Common Stockholders had a median value of $3.6 million in 2023 and averaged $3.9 million.
  • In the last 5 years, Escalade's Net Income towards Common Stockholders tumbled by 11430.72% in 2023 and then surged by 28644.96% in 2024.
  • Escalade's Net Income towards Common Stockholders (Quarter) stood at $4.9 million in 2021, then plummeted by 49.5% to $2.5 million in 2022, then plummeted by 40.12% to $1.5 million in 2023, then surged by 83.3% to $2.7 million in 2024, then skyrocketed by 105.7% to $5.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at $5.6 million for Q3 2025, versus $1.8 million for Q2 2025 and $2.6 million for Q1 2025.